Construction of a full-length iASPP expression plasmid pcDNA3.1(+)/iASPP and its biological activity

Plasmid

Volumn 62, Issue 1, 2009, Pages 10-15

  Liu, Ze Jun ^a   Gao, Xing ^a   Cai, Yun ^a   Yang, Xin ^a   Fu, Xiao Lan ^a   Chen, Jie ^a   Zhang, Xiao Bing ^a   Xin, Hai Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Expression plasmid; iASPP; Immunoprecipitation; p53

Indexed keywords

COMPLEMENTARY DNA; IASPP PROTEIN; INHIBITOR PROTEIN; PLASMID DNA; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; EUKARYOTE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CLONING, MOLECULAR; ELECTROPHORESIS; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OPEN READING FRAMES; PLASMIDS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

EUKARYOTA;

EID: 67349096045     PISSN: 0147619X     EISSN: 10959890     Source Type: Journal    
DOI: 10.1016/j.plasmid.2009.01.004     Document Type: Article

References (12)

1. Bergamaschi D., Samuels Y., O'Neil N.J., Trigiante G., Crook T., Hsieh J.K., O'Connor D.J., Zhong S., Campargue I., Tomlinson M.L., Kuwabara P.E., and Lu X. IASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat. Genet. 33 (2003) 162-167
2. Liu Z.J., Cai Y., Hou L., Gao X., Xin H.M., Lu X., Zhong S., Gu S.Z., and Chen J. Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells. Cancer Invest. 26 (2008) 878-882
3. Liu Z.J., Lu X., Zhang Y., Zhong S., Gu S.Z., Zhang X.B., Yang X., and Xin H.M. Downregulated mRNA expression of ASPP and the hypermethylation of the 5′-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett. 579 (2005) 1587-1590
4. Liu Z.J., Lu X., and Zhong S. ASPP-Apoptotic specific regulator of p53. BBA-Rev. Cancer 1756 (2005) 77-80
5. Liu Z.J., Xin H.M., Chen J., Lu X., Zhong S., Gu S.Z., Wang G., Liu L., Cai Y., and Hou L. A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53. Leukemia Res. 31 (2007) 1156-1158
6. Liu Z.J., Zhang Y., Zhang X.B., and Yang X. Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia 18 (2004) 880
7. Samuels-Lev Y., O'Connor D.J., Bergamaschi D., Trigiante G., Hsieh J.-K., Zhong S., Campargue I., Naumovski L., Crook T., and Lu X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8 (2001) 781-794
8. Slee E.A., Gillotin S., Bergamaschi D., Royer C., Llanos S., Ali S., Jin B., Trigiante G., and Lu X. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene 23 (2004) 9007-9016
9. Sullivan A., and Lu X. ASPP: a new family of oncogenes and tumour suppressor genes. Br. J. Cancer 96 (2007) 196-200
10. Trigiante G., and Lu X. ASPP and cancer. Nat. Rev. Cancer 6 (2006) 217-226
11. Zhang X., Diao S., Rao Q., Xing H., Liu H., Liao X., Wang M., and Wang J. Identification of a novel isoform of iASPP and its interaction with p53. J. Mol. Biol. 368 (2007) 1162-1171
12. Zhang X., Wang M., Zhou C., Chen S., and Wang J. The expression of iASPP in acute leukemias. Leukemia Res. 29 (2005) 179-183